Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion type Assertion NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_head.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion description "[To evaluate the impact of SERCA2a overexpression on SR Ca2+ handling in diabetic CM, we 1) generated transgenic rats harboring a human cytomegalovirus enhancer/chicken beta-actin promotor-controlled rat SERCA2 transgene (SERCA2-TGR), 2) characterized their SR phenotype, and 3) examined whether transgene expression may rescue SR Ca2+ transport in streptozotocin-induced diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_provenance.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion evidence source_evidence_literature NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_provenance.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion SIO_000772 12206992 NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_provenance.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion wasDerivedFrom befree-20140225 NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_provenance.
- NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_assertion wasGeneratedBy ECO_0000203 NP640791.RAHcD2lseDzJ_ucWn48yGpQqqv2Jd91E_OyFs8AQiykws130_provenance.